GLOMELA CREAM

Triple combination therapy containing tretinoin 0.05%, hydroquinone 4%, and fluocinolone acetonide 0.01% demonstrated clinical improvement in melasma severity and may correlate with enhanced quality-of-life outcomes. Studies suggest this combination approach may be particularly relevant for people of color, for whom melasma causes significant psychosocial distress and for whom quality-of-life assessment remains understudied.

Not specified in abstract Clinical, Cosmetic and Investigational Dermatology. 2026. PubMed →

Research indicates topical tretinoin and tretinoin precursors may diminish photoaging and contribute to thickening and restoration of skin collagen. Evidence suggests retinoids have diverse indications beyond traditional keratinization disorders, including treatment of acne, melasma, and other pigmentary and dermatological conditions.

Not specified in abstract Clinics in Dermatology. 2026. PubMed →

Topical tretinoin cream, when combined with intravenous methylprednisolone and topical corticosteroids, may support rapid improvement of bullous pemphigoid lesions while also benefiting concurrent disseminated superficial porokeratosis plaques. Studies suggest tretinoin may play an adjunctive role in managing complex dermatological presentations characterized by abnormal keratinization and inflammatory responses.

Not specified in abstract The Australasian Journal of Dermatology. 2026. PubMed →

Evidence indicates tretinoin, when formulated with minoxidil, phytantriol, and vitamin E, may support management of eyebrow hair density reduction occurring as an adverse effect of repeated laser tattoo removal treatments. Research suggests this combination may help support hair follicle health during post-laser recovery periods.

Not specified in abstract Cureus. 2026. PubMed →